• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Bipolar II Disorder: A Useful Concept?

Bipolar II Disorder: A Useful Concept?

August 1, 2006
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
How common is bipolar II disorder, and are we frequently missing the diagnosis?

The answer depends on who you talk to. On the one hand we have the extreme viewpoint of Akiskal and colleagues, who argue that half of all patients presenting with depression actually have bipolar II disorder and that if you dig deep enough, you will find not one or two varieties of bipolar disorder, but six! These include such species as bipolar I ½ (depression with protracted hypomania), bipolar II ½ (cyclothymic depression), and bipolar IV (hyperthymic depression) (Psychiatr Clin North Am 1999;22(3):517-34).

On the other side of the spectrum, we have stodgy old DSM-IV, which maintains that there are only two bipolars – I and II – and that the prevalence rate of bipolar II is only 1.6%. An excellent review of bipolar II disorder (Can J Psychiatry 2004;49:802-812) synthesizes recent epidemiological data and concludes that the true prevalence may be closer to 5% or 6%.

For us clinicians, the most crucial issue concerning bipolar II, regardless of its prevalence, is whether the diagnosis adds anything helpful to our treatment decisions. Since bipolar II patients almost always present to psychiatrists with depression, they are often mistakenly diagnosed with recurrent major depressive disorder. But does this “mistake” have negative treatment implications?

The few clinical trials conducted specifically with bipolar II patients imply that the answer is no. According to these studies, when you give depressed bipolar II patients SSRIs or SNRIs without mood stabilizers, they respond well, and switch rates to hypomania were quite low, in the range of 3%-8% (J Clin Psychopharmacol 1998;18:435-440; Bipolar Disord 2004;6:75-81).

What about those rare bipolar II patients who present to you with hypomania – surely, these patients should be treated differently from unipolar depressed patients. While most clinicians would say that hypomania responds to the same medications as mania (mood stabilizers and antipsychotics), a Medline search revealed no controlled clinical trials of medications specifically for the treatment of hypomania.

In the latest category bender, one group of researchers published a small study indicating that antidepressants actually act as mood stabilizers in patients with bipolar II (J Affect Disord 2006;92:205-14). In this pilot study, 10 patients with bipolar II were randomized to Lexapro (escitalopram) 10 mg/day vs. placebo for three months of treatment, and then each group crossed over to the other treatment arm for the next three months. The results? Lexapro was better than placebo in terms of improving depression and reducing the percentage of days in either depression or hypomania.

If these results are replicated in larger samples, we’ll have an even harder time arguing that distinguishing between bipolar II and depression is useful.

TCPR Verdict:
Is it Bipolar II? Or simply depression "plus?"
General Psychiatry
KEYWORDS bipolar_disorder
    www.thecarlatreport.com
    Issue Date: August 1, 2006
    SUBSCRIBE NOW
    Table Of Contents
    Bipolar Disorder in Children: Is the Diagnosis Valid?
    The STEP-BD Study: An Introduction
    Do Antidepressants Cause Switching?
    Bipolar II Disorder: A Useful Concept?
    Understanding the STEP-BD Study
    CATIE, STAR*D, STEP-BD
    DOWNLOAD NOW
    Featured Book
    • MFB6eCover.jpg

      Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

      Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto22709844.jpg
      General Psychiatry

      Psychopharm Commandment #10: Don’t Fear these Meds

      Surprising health benefits of our riskiest meds: Lithium, quetiapine, and clozapine.

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.